Track the Epiminder Limited share price and the full management transaction log of the company, a publicly traded company based in Australia. Shares are quoted on the AU market, under the supervision of ASX. Operating in the Healthcare & Pharma sector, Epiminder Limited has recorded 6 reports. Market capitalisation: €100k. The latest transaction was filed on 20 August 2026 (Purchase). Among the most active insiders: Jeffrey Sells. Every trade is accessible without an account.
6
Insider Decl.
n/a
Thresholds
€56,160
6 ops.
Buy Volume
n/a
n/a
Sell Volume
53Σ signal
Buys €56,160n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
45,475 shares@ A$0.45513.66% mcap100.0% of flowShareASXISINISIN AU0000432239ASX:2924-03090643-3A693404
6 of 6 declarations
About Epiminder Limited
Epiminder Limited is a company in the health and pharmaceutical sector, focused on developing innovative solutions for chronic disease monitoring. It is listed on the XASX market.